Michael Cripps
Concepts (368)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholecystectomy, Laparoscopic | 8 | 2023 | 52 | 3.770 |
Why?
| | Cholecystitis, Acute | 7 | 2024 | 23 | 2.830 |
Why?
| | Wounds and Injuries | 18 | 2025 | 897 | 2.670 |
Why?
| | Cholecystitis | 5 | 2023 | 23 | 2.090 |
Why?
| | Trauma Centers | 20 | 2026 | 450 | 1.920 |
Why?
| | Venous Thromboembolism | 6 | 2025 | 337 | 1.710 |
Why?
| | Severity of Illness Index | 7 | 2024 | 2903 | 1.330 |
Why?
| | Anticoagulants | 7 | 2025 | 675 | 1.270 |
Why?
| | Appendicitis | 4 | 2020 | 146 | 1.220 |
Why?
| | Emergency Treatment | 2 | 2020 | 125 | 1.130 |
Why?
| | Hemorrhage | 9 | 2024 | 760 | 1.110 |
Why?
| | Retrospective Studies | 44 | 2026 | 16374 | 0.990 |
Why?
| | Cholecystectomy | 4 | 2024 | 58 | 0.950 |
Why?
| | Postoperative Complications | 7 | 2021 | 2821 | 0.950 |
Why?
| | Resuscitation | 9 | 2024 | 283 | 0.910 |
Why?
| | Appendectomy | 3 | 2020 | 89 | 0.820 |
Why?
| | Injury Severity Score | 14 | 2026 | 560 | 0.820 |
Why?
| | Thrombelastography | 4 | 2021 | 175 | 0.770 |
Why?
| | Blood Coagulation | 3 | 2021 | 269 | 0.770 |
Why?
| | Enoxaparin | 4 | 2023 | 67 | 0.770 |
Why?
| | Adult | 51 | 2026 | 39391 | 0.760 |
Why?
| | Middle Aged | 45 | 2026 | 34647 | 0.710 |
Why?
| | Burns | 4 | 2023 | 349 | 0.710 |
Why?
| | Simulation Training | 2 | 2022 | 127 | 0.700 |
Why?
| | Operative Time | 7 | 2023 | 154 | 0.690 |
Why?
| | Time-to-Treatment | 2 | 2020 | 223 | 0.680 |
Why?
| | Abdomen | 2 | 2018 | 136 | 0.680 |
Why?
| | Rib Fractures | 1 | 2021 | 33 | 0.670 |
Why?
| | Laparoscopy | 3 | 2022 | 463 | 0.660 |
Why?
| | Prospective Studies | 19 | 2025 | 7777 | 0.650 |
Why?
| | Length of Stay | 8 | 2021 | 1263 | 0.640 |
Why?
| | Shock, Hemorrhagic | 5 | 2024 | 191 | 0.640 |
Why?
| | Humans | 87 | 2026 | 141754 | 0.630 |
Why?
| | Machine Learning | 2 | 2023 | 556 | 0.630 |
Why?
| | Critical Pathways | 1 | 2021 | 106 | 0.620 |
Why?
| | Nerve Block | 1 | 2021 | 97 | 0.620 |
Why?
| | Pain Management | 2 | 2021 | 396 | 0.620 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 377 | 0.610 |
Why?
| | Emergency Medical Services | 2 | 2023 | 650 | 0.610 |
Why?
| | Artificial Intelligence | 1 | 2023 | 337 | 0.600 |
Why?
| | Male | 57 | 2026 | 70179 | 0.600 |
Why?
| | Balloon Occlusion | 3 | 2024 | 36 | 0.590 |
Why?
| | Specialties, Surgical | 1 | 2020 | 80 | 0.590 |
Why?
| | Kaolin | 1 | 2018 | 5 | 0.590 |
Why?
| | Factor Xa | 1 | 2018 | 35 | 0.590 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2019 | 38 | 0.580 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 195 | 0.580 |
Why?
| | Female | 59 | 2026 | 75943 | 0.580 |
Why?
| | Vitamin K | 1 | 2018 | 42 | 0.570 |
Why?
| | End Stage Liver Disease | 1 | 2019 | 76 | 0.550 |
Why?
| | Hemostatics | 1 | 2018 | 58 | 0.550 |
Why?
| | Airway Extubation | 1 | 2018 | 60 | 0.550 |
Why?
| | Embolization, Therapeutic | 3 | 2024 | 242 | 0.540 |
Why?
| | Internship and Residency | 5 | 2026 | 1240 | 0.530 |
Why?
| | Tachycardia, Supraventricular | 1 | 2017 | 43 | 0.520 |
Why?
| | Atrial Flutter | 1 | 2017 | 39 | 0.520 |
Why?
| | Appendix | 1 | 2017 | 32 | 0.510 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1057 | 0.490 |
Why?
| | Pulmonary Embolism | 1 | 2019 | 239 | 0.490 |
Why?
| | Orthopedic Procedures | 1 | 2019 | 229 | 0.490 |
Why?
| | Clinical Competence | 3 | 2026 | 1205 | 0.490 |
Why?
| | Algorithms | 1 | 2023 | 1768 | 0.470 |
Why?
| | Texas | 5 | 2019 | 262 | 0.470 |
Why?
| | Blood Transfusion | 3 | 2021 | 393 | 0.460 |
Why?
| | Predictive Value of Tests | 6 | 2024 | 2075 | 0.460 |
Why?
| | Patient Safety | 1 | 2018 | 337 | 0.450 |
Why?
| | Triage | 2 | 2026 | 246 | 0.440 |
Why?
| | Treatment Outcome | 17 | 2024 | 11181 | 0.440 |
Why?
| | Biomedical Research | 1 | 2021 | 708 | 0.440 |
Why?
| | Critical Illness | 2 | 2019 | 837 | 0.440 |
Why?
| | Endovascular Procedures | 3 | 2024 | 356 | 0.440 |
Why?
| | Aged | 23 | 2026 | 24746 | 0.430 |
Why?
| | Practice Guidelines as Topic | 5 | 2026 | 1570 | 0.420 |
Why?
| | Hospitalization | 3 | 2022 | 2264 | 0.400 |
Why?
| | Surgeons | 3 | 2025 | 336 | 0.390 |
Why?
| | Atrial Fibrillation | 1 | 2017 | 384 | 0.390 |
Why?
| | Mass Screening | 4 | 2023 | 1313 | 0.360 |
Why?
| | Liver | 3 | 2024 | 1820 | 0.360 |
Why?
| | Hand-Assisted Laparoscopy | 1 | 2010 | 4 | 0.330 |
Why?
| | Wandering Spleen | 1 | 2010 | 2 | 0.330 |
Why?
| | Operating Rooms | 3 | 2022 | 146 | 0.300 |
Why?
| | Reproducibility of Results | 6 | 2021 | 3356 | 0.300 |
Why?
| | Head Injuries, Penetrating | 1 | 2009 | 7 | 0.300 |
Why?
| | Risk Assessment | 10 | 2021 | 3508 | 0.300 |
Why?
| | Outpatient Clinics, Hospital | 2 | 2020 | 82 | 0.300 |
Why?
| | Abdominal Injuries | 2 | 2020 | 122 | 0.300 |
Why?
| | Brain Injuries, Traumatic | 2 | 2026 | 400 | 0.300 |
Why?
| | Safety-net Providers | 3 | 2019 | 124 | 0.290 |
Why?
| | Abdominal Abscess | 2 | 2020 | 25 | 0.290 |
Why?
| | Geriatric Assessment | 2 | 2020 | 226 | 0.280 |
Why?
| | Logistic Models | 4 | 2024 | 2092 | 0.280 |
Why?
| | Time Factors | 9 | 2020 | 6966 | 0.280 |
Why?
| | Multiple Trauma | 1 | 2009 | 113 | 0.280 |
Why?
| | Emergency Service, Hospital | 5 | 2024 | 2193 | 0.270 |
Why?
| | Education, Medical, Graduate | 2 | 2026 | 526 | 0.270 |
Why?
| | Blood Coagulation Tests | 2 | 2018 | 73 | 0.270 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 2 | 2024 | 20 | 0.270 |
Why?
| | Hospitals | 2 | 2022 | 696 | 0.270 |
Why?
| | Tomography, X-Ray Computed | 7 | 2026 | 2765 | 0.260 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2018 | 55 | 0.260 |
Why?
| | Blood Coagulation Disorders | 2 | 2021 | 189 | 0.260 |
Why?
| | Glasgow Coma Scale | 4 | 2026 | 204 | 0.260 |
Why?
| | Aorta | 3 | 2024 | 424 | 0.250 |
Why?
| | Wounds, Gunshot | 2 | 2017 | 248 | 0.250 |
Why?
| | Advanced Trauma Life Support Care | 1 | 2026 | 4 | 0.240 |
Why?
| | Young Adult | 11 | 2023 | 13749 | 0.240 |
Why?
| | Quality Improvement | 4 | 2024 | 1254 | 0.240 |
Why?
| | Choledocholithiasis | 2 | 2015 | 19 | 0.240 |
Why?
| | Traumatology | 1 | 2026 | 40 | 0.230 |
Why?
| | Brain Injuries | 2 | 2025 | 502 | 0.230 |
Why?
| | Intracranial Hemorrhages | 1 | 2026 | 94 | 0.230 |
Why?
| | Facial Bones | 1 | 2025 | 30 | 0.220 |
Why?
| | Facial Injuries | 1 | 2025 | 23 | 0.220 |
Why?
| | Cause of Death | 3 | 2017 | 441 | 0.220 |
Why?
| | Subarachnoid Hemorrhage, Traumatic | 1 | 2024 | 4 | 0.220 |
Why?
| | Skull Fractures | 1 | 2025 | 38 | 0.220 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2025 | 96 | 0.220 |
Why?
| | Hepatic Artery | 1 | 2024 | 52 | 0.220 |
Why?
| | Wound Infection | 1 | 2025 | 37 | 0.220 |
Why?
| | Hematoma | 1 | 2024 | 54 | 0.210 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 122 | 0.210 |
Why?
| | Workload | 1 | 2025 | 166 | 0.200 |
Why?
| | Venous Thrombosis | 1 | 2025 | 192 | 0.200 |
Why?
| | Registries | 4 | 2024 | 2144 | 0.190 |
Why?
| | Adolescent | 7 | 2023 | 22130 | 0.190 |
Why?
| | Pelvic Bones | 1 | 2024 | 129 | 0.190 |
Why?
| | Aged, 80 and over | 6 | 2020 | 7923 | 0.190 |
Why?
| | ROC Curve | 2 | 2022 | 590 | 0.180 |
Why?
| | Health Plan Implementation | 2 | 2020 | 145 | 0.180 |
Why?
| | Time Perception | 1 | 2022 | 34 | 0.180 |
Why?
| | Surveys and Questionnaires | 5 | 2023 | 5974 | 0.180 |
Why?
| | Patient Handoff | 1 | 2021 | 38 | 0.180 |
Why?
| | Paraspinal Muscles | 1 | 2021 | 13 | 0.170 |
Why?
| | Hospital Mortality | 6 | 2021 | 924 | 0.170 |
Why?
| | Liver Failure, Acute | 1 | 2021 | 66 | 0.170 |
Why?
| | Wounds, Nonpenetrating | 1 | 2024 | 307 | 0.170 |
Why?
| | Observational Studies as Topic | 1 | 2021 | 124 | 0.170 |
Why?
| | Trauma Severity Indices | 1 | 2021 | 111 | 0.170 |
Why?
| | Altitude | 1 | 2025 | 476 | 0.170 |
Why?
| | Intubation, Intratracheal | 1 | 2023 | 288 | 0.170 |
Why?
| | General Surgery | 2 | 2020 | 199 | 0.170 |
Why?
| | Anesthetics, Local | 1 | 2021 | 101 | 0.160 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2021 | 1634 | 0.160 |
Why?
| | Risk Factors | 7 | 2024 | 10482 | 0.160 |
Why?
| | Bias | 1 | 2021 | 229 | 0.160 |
Why?
| | Soft Tissue Infections | 1 | 2020 | 41 | 0.160 |
Why?
| | United States Social Security Administration | 1 | 2019 | 2 | 0.160 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2021 | 138 | 0.160 |
Why?
| | Diphenoxylate | 1 | 2019 | 5 | 0.160 |
Why?
| | Laparotomy | 1 | 2020 | 115 | 0.160 |
Why?
| | Ileus | 1 | 2019 | 13 | 0.160 |
Why?
| | Loperamide | 1 | 2019 | 12 | 0.160 |
Why?
| | Metoclopramide | 1 | 2019 | 19 | 0.160 |
Why?
| | Erythromycin | 1 | 2019 | 20 | 0.160 |
Why?
| | Clinical Protocols | 2 | 2019 | 273 | 0.160 |
Why?
| | Fasciitis, Necrotizing | 1 | 2019 | 16 | 0.150 |
Why?
| | Mycoses | 1 | 2020 | 86 | 0.150 |
Why?
| | Diet Therapy | 1 | 2019 | 37 | 0.150 |
Why?
| | Antifungal Agents | 1 | 2020 | 144 | 0.150 |
Why?
| | Surgicenters | 1 | 2019 | 5 | 0.150 |
Why?
| | Fractures, Bone | 1 | 2024 | 406 | 0.150 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2018 | 6 | 0.150 |
Why?
| | United States | 12 | 2025 | 15310 | 0.150 |
Why?
| | Violence | 2 | 2023 | 276 | 0.150 |
Why?
| | Viscoelastic Substances | 1 | 2018 | 10 | 0.150 |
Why?
| | Education, Medical, Continuing | 1 | 2020 | 133 | 0.150 |
Why?
| | Hospitals, University | 1 | 2019 | 175 | 0.150 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2020 | 181 | 0.150 |
Why?
| | Dabigatran | 1 | 2018 | 23 | 0.150 |
Why?
| | Conversion to Open Surgery | 1 | 2018 | 17 | 0.150 |
Why?
| | Publishing | 1 | 2020 | 145 | 0.140 |
Why?
| | Pipecolic Acids | 1 | 2018 | 26 | 0.140 |
Why?
| | Program Evaluation | 2 | 2020 | 930 | 0.140 |
Why?
| | Diarrhea | 1 | 2019 | 184 | 0.140 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2019 | 75 | 0.140 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 178 | 0.140 |
Why?
| | Photoperiod | 1 | 2018 | 53 | 0.140 |
Why?
| | Bandages | 1 | 2018 | 42 | 0.140 |
Why?
| | Antithrombins | 1 | 2018 | 64 | 0.140 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 139 | 0.140 |
Why?
| | Surgical Wound Infection | 1 | 2021 | 321 | 0.140 |
Why?
| | Myocardial Contusions | 1 | 2017 | 2 | 0.140 |
Why?
| | Information Storage and Retrieval | 1 | 2018 | 120 | 0.140 |
Why?
| | Sex Factors | 2 | 2021 | 2063 | 0.140 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2020 | 232 | 0.140 |
Why?
| | Thorax | 1 | 2017 | 50 | 0.140 |
Why?
| | Multidetector Computed Tomography | 1 | 2017 | 40 | 0.130 |
Why?
| | Emergencies | 1 | 2018 | 179 | 0.130 |
Why?
| | Enteral Nutrition | 1 | 2019 | 202 | 0.130 |
Why?
| | Tachycardia | 1 | 2017 | 55 | 0.130 |
Why?
| | Surgical Procedures, Operative | 1 | 2020 | 270 | 0.130 |
Why?
| | Thoracic Vertebrae | 1 | 2017 | 78 | 0.130 |
Why?
| | Incidence | 3 | 2019 | 2806 | 0.130 |
Why?
| | Spinal Injuries | 1 | 2017 | 57 | 0.130 |
Why?
| | Smartphone | 1 | 2018 | 91 | 0.130 |
Why?
| | Blood Viscosity | 1 | 2016 | 18 | 0.130 |
Why?
| | Arginine | 1 | 2018 | 260 | 0.130 |
Why?
| | Accidental Falls | 1 | 2020 | 216 | 0.130 |
Why?
| | Patient Transfer | 1 | 2019 | 181 | 0.130 |
Why?
| | Electronic Health Records | 1 | 2025 | 1132 | 0.130 |
Why?
| | Occupational Injuries | 1 | 2017 | 44 | 0.130 |
Why?
| | Police | 1 | 2017 | 45 | 0.130 |
Why?
| | Factor Xa Inhibitors | 1 | 2018 | 175 | 0.130 |
Why?
| | Heparin | 1 | 2018 | 259 | 0.130 |
Why?
| | Cohort Studies | 3 | 2020 | 5815 | 0.130 |
Why?
| | Pelvis | 1 | 2017 | 115 | 0.130 |
Why?
| | Photography | 1 | 2017 | 115 | 0.130 |
Why?
| | Anti-Bacterial Agents | 2 | 2025 | 1866 | 0.130 |
Why?
| | Physical Therapy Modalities | 1 | 2020 | 319 | 0.120 |
Why?
| | Research Design | 1 | 2023 | 1146 | 0.120 |
Why?
| | Rivaroxaban | 1 | 2018 | 259 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 619 | 0.120 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 112 | 0.120 |
Why?
| | Blood Safety | 1 | 2015 | 11 | 0.120 |
Why?
| | Lumbar Vertebrae | 1 | 2017 | 251 | 0.120 |
Why?
| | Radiography, Interventional | 1 | 2016 | 122 | 0.120 |
Why?
| | Substance Abuse Detection | 1 | 2017 | 105 | 0.120 |
Why?
| | Critical Care | 1 | 2021 | 650 | 0.110 |
Why?
| | Platelet Transfusion | 1 | 2016 | 78 | 0.110 |
Why?
| | Medical Marijuana | 1 | 2017 | 125 | 0.110 |
Why?
| | Cryopreservation | 1 | 2015 | 106 | 0.110 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2018 | 475 | 0.110 |
Why?
| | Sulfonamides | 1 | 2018 | 567 | 0.110 |
Why?
| | Benchmarking | 1 | 2015 | 180 | 0.110 |
Why?
| | Decision Support Systems, Clinical | 1 | 2018 | 263 | 0.110 |
Why?
| | Watchful Waiting | 2 | 2024 | 85 | 0.100 |
Why?
| | Exsanguination | 1 | 2013 | 20 | 0.100 |
Why?
| | Angiography | 2 | 2024 | 207 | 0.100 |
Why?
| | Erythrocyte Transfusion | 1 | 2015 | 208 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1498 | 0.100 |
Why?
| | Burn Units | 3 | 2019 | 48 | 0.100 |
Why?
| | International Cooperation | 1 | 2014 | 203 | 0.100 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 327 | 0.100 |
Why?
| | Patient Discharge | 1 | 2019 | 933 | 0.090 |
Why?
| | Chronic Pain | 1 | 2017 | 280 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2016 | 431 | 0.090 |
Why?
| | Antifibrinolytic Agents | 1 | 2012 | 57 | 0.090 |
Why?
| | Age Factors | 5 | 2020 | 3294 | 0.090 |
Why?
| | Blood Preservation | 1 | 2015 | 307 | 0.090 |
Why?
| | Educational Measurement | 2 | 2026 | 319 | 0.090 |
Why?
| | Suicide | 1 | 2018 | 671 | 0.080 |
Why?
| | Child Abuse | 1 | 2016 | 547 | 0.080 |
Why?
| | Surgical Mesh | 1 | 2010 | 52 | 0.080 |
Why?
| | Propensity Score | 2 | 2025 | 332 | 0.080 |
Why?
| | Gastrointestinal Motility | 2 | 2019 | 28 | 0.080 |
Why?
| | Malaria | 1 | 2010 | 66 | 0.080 |
Why?
| | Splanchnic Circulation | 1 | 2009 | 12 | 0.080 |
Why?
| | Tungsten | 1 | 2009 | 30 | 0.080 |
Why?
| | Xanthine Oxidase | 1 | 2009 | 81 | 0.070 |
Why?
| | Survival Rate | 3 | 2020 | 1972 | 0.070 |
Why?
| | Capillary Permeability | 1 | 2009 | 149 | 0.070 |
Why?
| | Follow-Up Studies | 4 | 2020 | 5212 | 0.070 |
Why?
| | Acute Disease | 2 | 2023 | 1010 | 0.070 |
Why?
| | Guideline Adherence | 2 | 2025 | 566 | 0.070 |
Why?
| | Substance-Related Disorders | 1 | 2017 | 1102 | 0.070 |
Why?
| | Databases, Factual | 3 | 2019 | 1448 | 0.070 |
Why?
| | Delivery of Health Care | 1 | 2014 | 962 | 0.060 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 2 | 2021 | 213 | 0.060 |
Why?
| | Analysis of Variance | 2 | 2021 | 1321 | 0.060 |
Why?
| | Ultrasonography | 2 | 2023 | 761 | 0.060 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2025 | 37 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1249 | 0.060 |
Why?
| | HIV Infections | 1 | 2019 | 3022 | 0.050 |
Why?
| | Radiology, Interventional | 1 | 2024 | 34 | 0.050 |
Why?
| | Neurosurgical Procedures | 1 | 2025 | 210 | 0.050 |
Why?
| | Common Bile Duct | 1 | 2023 | 14 | 0.050 |
Why?
| | Computed Tomography Angiography | 1 | 2024 | 134 | 0.050 |
Why?
| | Comorbidity | 2 | 2019 | 1664 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 47 | 0.050 |
Why?
| | Sex Chromosome Aberrations | 2 | 1982 | 68 | 0.050 |
Why?
| | Hypoxia | 1 | 2009 | 1165 | 0.040 |
Why?
| | Delphi Technique | 1 | 2023 | 313 | 0.040 |
Why?
| | Contrast Media | 1 | 2024 | 470 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5697 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1977 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 547 | 0.040 |
Why?
| | Antidiarrheals | 1 | 2019 | 14 | 0.040 |
Why?
| | Renal Replacement Therapy | 1 | 2020 | 93 | 0.040 |
Why?
| | Data Collection | 1 | 2022 | 662 | 0.040 |
Why?
| | Necrosis | 1 | 2020 | 249 | 0.040 |
Why?
| | Debridement | 1 | 2019 | 88 | 0.040 |
Why?
| | Early Medical Intervention | 1 | 2019 | 60 | 0.040 |
Why?
| | Europe | 1 | 2020 | 411 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2019 | 67 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 322 | 0.040 |
Why?
| | Fungi | 1 | 2020 | 152 | 0.040 |
Why?
| | Curriculum | 1 | 2026 | 1039 | 0.040 |
Why?
| | Population Dynamics | 1 | 2019 | 153 | 0.040 |
Why?
| | Acetaminophen | 1 | 2021 | 264 | 0.040 |
Why?
| | Independent Living | 1 | 2020 | 112 | 0.040 |
Why?
| | Growth Disorders | 1 | 1979 | 87 | 0.040 |
Why?
| | Hospital Costs | 1 | 2019 | 122 | 0.040 |
Why?
| | Organizational Innovation | 1 | 2019 | 138 | 0.040 |
Why?
| | Prognosis | 2 | 2018 | 4080 | 0.030 |
Why?
| | Infant | 4 | 2023 | 9843 | 0.030 |
Why?
| | Safety | 1 | 2020 | 356 | 0.030 |
Why?
| | California | 1 | 2019 | 466 | 0.030 |
Why?
| | Leadership | 1 | 2022 | 399 | 0.030 |
Why?
| | Child, Preschool | 4 | 2023 | 11512 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2017 | 147 | 0.030 |
Why?
| | Military Personnel | 1 | 2024 | 615 | 0.030 |
Why?
| | Homicide | 1 | 2017 | 66 | 0.030 |
Why?
| | Postural Balance | 1 | 2020 | 238 | 0.030 |
Why?
| | Probability | 1 | 2017 | 309 | 0.030 |
Why?
| | Burns, Chemical | 1 | 2016 | 32 | 0.030 |
Why?
| | Counseling | 1 | 2019 | 398 | 0.030 |
Why?
| | Elasticity | 1 | 2016 | 194 | 0.030 |
Why?
| | Accidents, Traffic | 1 | 2017 | 190 | 0.030 |
Why?
| | Biliary Tract | 1 | 2015 | 14 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 60 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2020 | 1027 | 0.030 |
Why?
| | Learning | 1 | 2020 | 439 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2017 | 139 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2020 | 685 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 859 | 0.030 |
Why?
| | Liver Function Tests | 1 | 2015 | 105 | 0.030 |
Why?
| | Blood Banks | 1 | 2015 | 47 | 0.030 |
Why?
| | Age Distribution | 1 | 2016 | 397 | 0.030 |
Why?
| | Communication | 1 | 2021 | 951 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 807 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 587 | 0.030 |
Why?
| | Hospitals, Urban | 1 | 2015 | 137 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2017 | 244 | 0.030 |
Why?
| | Risk | 1 | 2017 | 907 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 434 | 0.030 |
Why?
| | Pain Measurement | 1 | 2017 | 554 | 0.030 |
Why?
| | Liver Diseases | 1 | 2017 | 301 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1826 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1268 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1320 | 0.030 |
Why?
| | India | 1 | 2014 | 208 | 0.030 |
Why?
| | Guatemala | 1 | 2014 | 347 | 0.020 |
Why?
| | International Normalized Ratio | 1 | 2012 | 48 | 0.020 |
Why?
| | Partial Thromboplastin Time | 1 | 2012 | 53 | 0.020 |
Why?
| | Platelet Count | 1 | 2012 | 89 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2799 | 0.020 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 93 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 284 | 0.020 |
Why?
| | Child | 3 | 2023 | 22414 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2015 | 1989 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3737 | 0.020 |
Why?
| | Alcoholism | 1 | 2017 | 823 | 0.020 |
Why?
| | Venules | 1 | 2009 | 15 | 0.020 |
Why?
| | Mesocricetus | 1 | 2009 | 45 | 0.020 |
Why?
| | Reperfusion | 1 | 2009 | 44 | 0.020 |
Why?
| | Cricetinae | 1 | 2009 | 301 | 0.020 |
Why?
| | Disease Progression | 1 | 2014 | 2800 | 0.020 |
Why?
| | Pregnancy | 1 | 2017 | 7092 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2525 | 0.010 |
Why?
| | Luteinizing Hormone | 2 | 1982 | 183 | 0.010 |
Why?
| | Growth | 1 | 1982 | 52 | 0.010 |
Why?
| | Aneuploidy | 1 | 1982 | 89 | 0.010 |
Why?
| | Follicle Stimulating Hormone | 2 | 1982 | 243 | 0.010 |
Why?
| | Diet | 1 | 2009 | 1282 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5637 | 0.010 |
Why?
| | Y Chromosome | 1 | 1979 | 11 | 0.010 |
Why?
| | X Chromosome | 1 | 1979 | 55 | 0.010 |
Why?
| | Bone Development | 1 | 1979 | 54 | 0.010 |
Why?
| | Intellectual Disability | 1 | 1979 | 173 | 0.010 |
Why?
| | Child Development | 1 | 1982 | 499 | 0.010 |
Why?
| | Infant, Newborn | 2 | 1982 | 6289 | 0.010 |
Why?
| | Animals | 1 | 2009 | 37749 | 0.000 |
Why?
| | Psychology, Child | 1 | 1982 | 39 | 0.000 |
Why?
| | Sexual Maturation | 1 | 1982 | 55 | 0.000 |
Why?
| | Body Height | 1 | 1982 | 200 | 0.000 |
Why?
| | Gonadal Steroid Hormones | 1 | 1982 | 139 | 0.000 |
Why?
| | Body Weight | 1 | 1982 | 997 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1982 | 2938 | 0.000 |
Why?
|
|
Cripps's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|